Black Rock Inc. Spring Works Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,619,260 shares of SWTX stock, worth $264 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,619,260
Previous 5,438,857
3.32%
Holding current value
$264 Million
Previous $268 Million
20.93%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
26Shares Held
7.39MCall Options Held
23KPut Options Held
11-
Pictet Asset Management Sa Geneva 73, V81.06MShares$49.9 Million0.03% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL273KShares$12.9 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL184KShares$8.63 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V859.2KShares$2.78 Million0.0% of portfolio
-
Deka Bank Deutsche Girozentrale40KShares$1.88 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...